• Like
  • Comment
  • Favorite

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

Zacks04-11

ALX Oncology Holdings Inc. ALXO reported positive results from an ongoing phase I/II investigator-sponsored study of evorpacept, in combination with Roche’s RHHBY Rituxan (rituximab) and Bristol Myers...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial